BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32275190)

  • 1. Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carries a Moderately Increased Risk of Death.
    Sunden-Cullberg J
    Hypertension; 2020 Jun; 75(6):e15-e16. PubMed ID: 32275190
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
    Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H
    Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus.
    Verdecchia P; Angeli F; Reboldi G
    J Hypertens; 2020 Jun; 38(6):1190-1191. PubMed ID: 32371811
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Gersh FL
    Mayo Clin Proc; 2020 Jul; 95(7):1552-1553. PubMed ID: 32622456
    [No Abstract]   [Full Text] [Related]  

  • 5. Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Kansagara D; Mackey K; Vela K
    Ann Intern Med; 2020 Aug; 173(3):W66. PubMed ID: 32584593
    [No Abstract]   [Full Text] [Related]  

  • 6. Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Mackey K; Kansagara D; Vela K
    Ann Intern Med; 2020 Sep; 173(5):W87. PubMed ID: 32701362
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.
    Kussmaul WG
    Ann Intern Med; 2020 Aug; 173(3):237-238. PubMed ID: 32422077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Mackey K; Kansagara D; Vela K
    Ann Intern Med; 2020 Oct; 173(7):130-131. PubMed ID: 32845705
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 10. ACEing COVID-19: A Role for Angiotensin Axis Inhibition in SARS-CoV-2 Infection?
    Murthy VL; Koupenova M; Shah RV
    Circ Res; 2020 Jun; 126(12):1682-1684. PubMed ID: 32302248
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
    Diaz JH
    J Travel Med; 2020 May; 27(3):. PubMed ID: 32186711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic".
    Ferrario CM
    Diabetes Metab Syndr; 2020; 14(5):1401-1402. PubMed ID: 32755842
    [No Abstract]   [Full Text] [Related]  

  • 13. Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.
    Otto CM
    Heart; 2020 Oct; 106(19):1451-1453. PubMed ID: 32928982
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply: ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.
    Amat-Santos IJ; Santos-Martinez S; López-Otero D; Delgado-Arana JR; San Román JA
    J Am Coll Cardiol; 2020 Oct; 76(17):2042. PubMed ID: 33092743
    [No Abstract]   [Full Text] [Related]  

  • 15. In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Sanchis-Gomar F; Lavie CJ; Perez-Quilis C; Henry BM; Lippi G
    Mayo Clin Proc; 2020 Jul; 95(7):1553-1556. PubMed ID: 32622458
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Guo J; Huang Z; Lin L; Lv J
    J Am Heart Assoc; 2020 Apr; 9(7):e016219. PubMed ID: 32233755
    [No Abstract]   [Full Text] [Related]  

  • 17. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score.
    Vavougios GD
    Crit Care; 2020 May; 24(1):242. PubMed ID: 32430049
    [No Abstract]   [Full Text] [Related]  

  • 19. ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19.
    Wang Y; Tse G; Li G; Lip GYH; Liu T
    J Am Coll Cardiol; 2020 Oct; 76(17):2041. PubMed ID: 33092742
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
    Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Feldman A; D'Andréa Saba Arruda G; de Souza AS; de Albuquerque DC; Mazza L; Santos MF; Salvador NZ; Gibson CM; Granger CB; Alexander JH; de Souza OF;
    Am Heart J; 2020 Aug; 226():49-59. PubMed ID: 32502882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.